Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adolescent Behavior | 15 | 2026 | 281 | 4.430 |
Why?
|
| Substance-Related Disorders | 19 | 2025 | 830 | 3.170 |
Why?
|
| Peer Group | 10 | 2026 | 177 | 2.770 |
Why?
|
| Receptors, GABA-A | 7 | 2019 | 65 | 2.680 |
Why?
|
| Parenting | 7 | 2024 | 137 | 2.520 |
Why?
|
| Alcoholism | 17 | 2026 | 305 | 2.310 |
Why?
|
| Adolescent | 46 | 2026 | 6081 | 2.310 |
Why?
|
| Juvenile Delinquency | 8 | 2021 | 44 | 1.790 |
Why?
|
| Acculturation | 2 | 2025 | 205 | 1.570 |
Why?
|
| Longitudinal Studies | 23 | 2026 | 1063 | 1.520 |
Why?
|
| Alcohol Drinking | 12 | 2024 | 609 | 1.420 |
Why?
|
| Child | 27 | 2026 | 3443 | 1.420 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2022 | 734 | 1.300 |
Why?
|
| Male | 51 | 2026 | 23409 | 1.180 |
Why?
|
| Female | 51 | 2026 | 24698 | 1.140 |
Why?
|
| Depression | 9 | 2026 | 863 | 1.120 |
Why?
|
| Humans | 68 | 2026 | 43102 | 1.080 |
Why?
|
| Residence Characteristics | 3 | 2026 | 363 | 0.980 |
Why?
|
| Aggression | 6 | 2020 | 102 | 0.940 |
Why?
|
| Temperament | 4 | 2021 | 36 | 0.920 |
Why?
|
| Genotype | 6 | 2021 | 800 | 0.870 |
Why?
|
| Child Abuse | 2 | 2023 | 92 | 0.870 |
Why?
|
| Affective Symptoms | 6 | 2026 | 63 | 0.860 |
Why?
|
| Cannabis | 2 | 2023 | 90 | 0.840 |
Why?
|
| Marijuana Smoking | 3 | 2023 | 91 | 0.840 |
Why?
|
| Affect | 1 | 2025 | 180 | 0.840 |
Why?
|
| Anxiety | 6 | 2024 | 874 | 0.810 |
Why?
|
| Mother-Child Relations | 1 | 2024 | 64 | 0.810 |
Why?
|
| Goals | 2 | 2013 | 34 | 0.750 |
Why?
|
| Emotions | 7 | 2022 | 254 | 0.740 |
Why?
|
| Risk Factors | 15 | 2022 | 3994 | 0.660 |
Why?
|
| Internal-External Control | 3 | 2019 | 63 | 0.650 |
Why?
|
| Marijuana Abuse | 4 | 2018 | 100 | 0.640 |
Why?
|
| Prospective Studies | 10 | 2024 | 1600 | 0.640 |
Why?
|
| Self Concept | 2 | 2013 | 171 | 0.600 |
Why?
|
| Negotiating | 1 | 2018 | 27 | 0.540 |
Why?
|
| Interpersonal Relations | 3 | 2017 | 222 | 0.510 |
Why?
|
| Brain | 4 | 2025 | 1472 | 0.490 |
Why?
|
| Social Behavior Disorders | 1 | 2016 | 5 | 0.490 |
Why?
|
| Attitude to Health | 1 | 2018 | 338 | 0.480 |
Why?
|
| Parents | 5 | 2023 | 370 | 0.460 |
Why?
|
| Self Efficacy | 3 | 2024 | 215 | 0.450 |
Why?
|
| Adolescent Development | 2 | 2018 | 40 | 0.440 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 250 | 0.420 |
Why?
|
| Personality Development | 1 | 2013 | 8 | 0.410 |
Why?
|
| Parent-Child Relations | 3 | 2024 | 127 | 0.400 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2017 | 15 | 0.380 |
Why?
|
| Alleles | 3 | 2019 | 352 | 0.370 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 1081 | 0.370 |
Why?
|
| Adult | 17 | 2026 | 13872 | 0.360 |
Why?
|
| Personality Assessment | 1 | 2011 | 45 | 0.350 |
Why?
|
| Social Adjustment | 1 | 2011 | 30 | 0.350 |
Why?
|
| Young Adult | 12 | 2024 | 5080 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 863 | 0.340 |
Why?
|
| Michigan | 4 | 2020 | 57 | 0.330 |
Why?
|
| Child, Preschool | 4 | 2024 | 1546 | 0.320 |
Why?
|
| Conduct Disorder | 2 | 2021 | 54 | 0.310 |
Why?
|
| Theory of Mind | 2 | 2020 | 4 | 0.310 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2021 | 16 | 0.300 |
Why?
|
| Prefrontal Cortex | 2 | 2025 | 164 | 0.300 |
Why?
|
| Psychometrics | 1 | 2011 | 358 | 0.290 |
Why?
|
| Students | 2 | 2024 | 626 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2025 | 587 | 0.270 |
Why?
|
| Asthma | 2 | 2021 | 416 | 0.260 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3156 | 0.240 |
Why?
|
| Dissociative Disorders | 1 | 2026 | 19 | 0.240 |
Why?
|
| Temporal Lobe | 1 | 2025 | 26 | 0.240 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 298 | 0.230 |
Why?
|
| Memory, Short-Term | 1 | 2025 | 59 | 0.230 |
Why?
|
| Impulsive Behavior | 3 | 2021 | 55 | 0.220 |
Why?
|
| Attitude | 2 | 2018 | 108 | 0.220 |
Why?
|
| Ethanol | 2 | 2023 | 224 | 0.200 |
Why?
|
| Models, Psychological | 2 | 2016 | 140 | 0.200 |
Why?
|
| Social Isolation | 1 | 2023 | 34 | 0.200 |
Why?
|
| Alcohol-Related Disorders | 2 | 2018 | 63 | 0.190 |
Why?
|
| Quality of Life | 3 | 2022 | 616 | 0.190 |
Why?
|
| New York | 2 | 2014 | 93 | 0.190 |
Why?
|
| Interviews as Topic | 1 | 2024 | 452 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2024 | 760 | 0.190 |
Why?
|
| Sleep | 1 | 2024 | 185 | 0.180 |
Why?
|
| Anxiety Disorders | 3 | 2022 | 322 | 0.180 |
Why?
|
| Factor Analysis, Statistical | 2 | 2021 | 162 | 0.180 |
Why?
|
| Rhinitis | 1 | 2021 | 18 | 0.180 |
Why?
|
| Mothers | 1 | 2024 | 215 | 0.180 |
Why?
|
| Risk | 3 | 2020 | 287 | 0.180 |
Why?
|
| Intention | 1 | 2022 | 108 | 0.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 70 | 0.170 |
Why?
|
| Preventive Medicine | 1 | 2021 | 16 | 0.170 |
Why?
|
| Awareness | 1 | 2021 | 73 | 0.170 |
Why?
|
| Binge-Eating Disorder | 1 | 2020 | 8 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2018 | 183 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 423 | 0.160 |
Why?
|
| Commerce | 1 | 2021 | 95 | 0.160 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 31 | 0.150 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 55 | 0.150 |
Why?
|
| Family | 1 | 2020 | 195 | 0.150 |
Why?
|
| Registries | 1 | 2021 | 437 | 0.140 |
Why?
|
| Gender Identity | 2 | 2011 | 117 | 0.140 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2018 | 22 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 64 | 0.140 |
Why?
|
| Defense Mechanisms | 1 | 2018 | 10 | 0.140 |
Why?
|
| Schools | 1 | 2020 | 283 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 310 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 25 | 0.140 |
Why?
|
| Mental Health | 1 | 2022 | 385 | 0.130 |
Why?
|
| Smoking | 3 | 2020 | 1024 | 0.130 |
Why?
|
| Inpatients | 2 | 2018 | 78 | 0.130 |
Why?
|
| Substance Abuse Detection | 2 | 2008 | 31 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 81 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2018 | 187 | 0.130 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 106 | 0.120 |
Why?
|
| Arousal | 1 | 2016 | 95 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2017 | 321 | 0.120 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 100 | 0.120 |
Why?
|
| Socialization | 1 | 2015 | 23 | 0.110 |
Why?
|
| Reward | 1 | 2016 | 112 | 0.110 |
Why?
|
| Models, Statistical | 2 | 2018 | 195 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 110 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2019 | 1604 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2026 | 282 | 0.100 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2014 | 26 | 0.100 |
Why?
|
| Poverty Areas | 1 | 2014 | 47 | 0.100 |
Why?
|
| Social Control, Informal | 1 | 2013 | 10 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 35 | 0.100 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.100 |
Why?
|
| Social Behavior | 1 | 2013 | 161 | 0.090 |
Why?
|
| Psychotherapy, Group | 2 | 2014 | 23 | 0.090 |
Why?
|
| Character | 1 | 2011 | 2 | 0.090 |
Why?
|
| Hierarchy, Social | 1 | 2011 | 9 | 0.090 |
Why?
|
| Life Style | 1 | 2013 | 334 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 87 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2014 | 430 | 0.090 |
Why?
|
| Amygdala | 2 | 2022 | 125 | 0.080 |
Why?
|
| Social Identification | 1 | 2011 | 65 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 306 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1154 | 0.080 |
Why?
|
| Neoplasms | 1 | 2021 | 1377 | 0.080 |
Why?
|
| Prevalence | 2 | 2020 | 1612 | 0.070 |
Why?
|
| Motivation | 1 | 2013 | 513 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2022 | 86 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 719 | 0.070 |
Why?
|
| Deception | 1 | 2007 | 7 | 0.060 |
Why?
|
| Counseling | 1 | 2007 | 138 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1285 | 0.050 |
Why?
|
| Hospitalization | 1 | 2007 | 485 | 0.050 |
Why?
|
| Florida | 1 | 2024 | 478 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 34 | 0.040 |
Why?
|
| United States | 3 | 2020 | 5205 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 33 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 70 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 37 | 0.040 |
Why?
|
| Taxes | 1 | 2021 | 14 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 60 | 0.040 |
Why?
|
| Data Collection | 1 | 2021 | 210 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2021 | 44 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 64 | 0.040 |
Why?
|
| Sweden | 1 | 2020 | 18 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 201 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2020 | 34 | 0.040 |
Why?
|
| Universities | 1 | 2024 | 559 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 78 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 163 | 0.040 |
Why?
|
| Attention | 1 | 2021 | 174 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 184 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Emotional Intelligence | 1 | 2017 | 8 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Public Health | 1 | 2021 | 424 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 408 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1028 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2018 | 457 | 0.030 |
Why?
|
| Negativism | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 44 | 0.030 |
Why?
|
| Haplotypes | 1 | 2014 | 197 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 45 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 317 | 0.030 |
Why?
|
| Mass Screening | 1 | 2018 | 541 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2544 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2014 | 233 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 339 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 445 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 737 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2014 | 661 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2007 | 10 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2007 | 48 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 56 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 74 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 102 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 180 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 1067 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 8214 | 0.010 |
Why?
|